Fig. 12
![Fig. 12](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs42269-022-00783-3/MediaObjects/42269_2022_783_Fig12_HTML.png)
Assessment of liver glycogen content in alloxan-induced diabetic rats when treated with EMZSB. Values were presented as mean ± SEM (n = 6), statistics employed was one-way ANOVA followed by Tukey’s multiple comparison test. $p < 0.01 when compared with normal control; *p < 0.05, **p < 0.01 when compared with diabetic control. Treatment of diabetic rats with EMZSB 250 mg kg−1 elucidated a significant increment in liver glycogen content as compared to diabetic control rats. Gray bar normal control, red diabetic control, brown bar diabetic + glimepiride, blue bar diabetic + EMZSB 150, yellow bar diabetic + EMZSB 200, green bar diabetic + EMZSB 250